SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-053413
Filing Date
2020-04-29
Accepted
2020-04-29 16:30:20
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A a20-2023_1defa14a.htm DEFA14A 32961
2 GRAPHIC g20231bgi001.gif GRAPHIC 64918
3 GRAPHIC g20231bgi002.gif GRAPHIC 86128
4 GRAPHIC g20231bgi003.gif GRAPHIC 28979
5 GRAPHIC g20231bgi004.gif GRAPHIC 3977
  Complete submission text file 0001104659-20-053413.txt   287910
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 20830780
SIC: 2834 Pharmaceutical Preparations